a melphalan-resistant human rhabdomyosarcoma xenograft , te-671 mr , was established in athymic mice by serial melphalan treatment of the parent xenograft , te-671 , at the 10 % lethal dosage ( ld10 ) ;
C0035412
rhabdomyosarcoma
C0025241
melphalan